Related Experiment Videos
Neoral conversion in stable thoracic transplant patients leads to dose reduction
D B Zaldonis1, R J Keenan, S M Pham
1Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
Transplantation Proceedings
|September 2, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lung Donation After Controlled Circulatory Determination of Death: A Review of Current Practices and Outcomes.
Transplantation proceedings·2015
Successful lung salvage by ex vivo reconditioning of neurogenic pulmonary edema: case report.
Transplantation proceedings·2014
Gender differences in patterns of emotional distress following heart transplantation.
Journal of clinical psychology in medical settings·2013
I.V. infusion of a drag-reducing polymer extracted from aloe vera prolonged survival time in a rat model of acute myocardial ischaemia.
British journal of anaesthesia·2006
Preservation of post-transplant lung function with aerosol cyclosporin.
The European respiratory journal·2004
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans.
The European respiratory journal·2004
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Apoptosis-Related Molecular Signatures in Calcineurin Inhibitor Nephrotoxicity After Kidney Transplantation.
Transplantation proceedings·2026
Antisense oligonucleotide selection scheme for rare Duchenne muscular dystrophy mutations: Application to DMD exon 16 skipping.
Molecular therapy. Nucleic acids·2026
Split intron-exon system for circular RNA synthesis.
Nature communications·2026
Hydrogen flux and microbial interactions governing methane formation in the rumen: Implications for mitigation.
The Science of the total environment·2026
Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis.
Science (New York, N.Y.)·2026